Company / EPS (Diluted)
Ventyx Biosciences, Inc. EPS (Diluted) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.97
FY2024
5-year range
-$6.65 / -$1.97
FY2021-FY2024
Trend
+40.3%
vs FY2023
Sector context
#126 of 203
Health Care
What the data says
At $-1.97, Ventyx Biosciences, Inc.'s eps (diluted) ranks #126 of 203 in the Health Care sector. Improved from $-2.07 to $-1.97 over the past 2 years.
Based on SEC 10-K filings.
-1.97 in FY2024.
Improved from $-2.07 to $-1.97 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 203 in Health CareTop 62% of 203This company -$1.97 Sector average -$0.45
▼
-339.2% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 40.3% year-over-year.
- Ranks #126 out of 203 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.97 | +40.3% |
| FY2023 | -$3.30 | -59.4% |
| FY2022 | -$2.07 | +68.9% |
| FY2021 | -$6.65 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026